Fundz

Gemphire Therapeutics Inc. reported raising $12.5 Million in an initial SEC Form D filing, from an offering of $12.5 Million

PUBLIC · MTVAMar 30, 2017

Amount Raised

$12.5 Million

$12.5 Million sold, per SEC Form D (first sale Mar 30, 2017)

Round Type

Venture

CambridgeBiotechnologyHealthcare

Quick answer

MetaVia raised $12.5 Million in a funding round, dated March 30, 2017. MetaVia is based in Cambridge, Massachusetts, United States.

How much did MetaVia raise?
MetaVia raised $12.5 Million in a funding round on March 30, 2017.
What does MetaVia do?
MetaVia (Nasdaq: MTVA) is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases.
Where is MetaVia based and how big is it?
MetaVia is based in Cambridge, Massachusetts, United States. Fundz records about 13 employees.
Who are the decision-makers at MetaVia?
Fundz holds 1 contact at MetaVia. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as MetaVia that raised within 45 days of this round, from Fundz verified event records.

  • Treace raised $5.9M on May 10, 2017.
  • Elite Pharmaceuticals raised $800K (Seed) on May 10, 2017.
  • Infinite Arthroscopy Inc., Ltd raised an undisclosed amount on May 9, 2017.
  • Forest Devices, Inc. raised $100K (Pre-Seed) on May 8, 2017.
  • X4 Pharmaceuticals raised $46M on May 8, 2017.
  • Optimvia raised an undisclosed amount on May 8, 2017.

Who to call at MetaVia, and when

A new round usually means MetaVia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MetaVia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MetaVia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MetaVia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MetaVia

Location

545 CONCORD AVENUE

Cambridge, Massachusetts, United States

About

MetaVia (Nasdaq: MTVA) is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity and DA-1241 for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MetaVia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts48 people are listed at MetaVia. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MetaVia's next move

See what Strategic adds

MetaVia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.